ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 15 filers reported holding ARCA BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $466,237 | -1.0% | 231,959 | 0.0% | 0.00% | – |
| Q2 2023 | $470,876 | -10.6% | 231,959 | -12.4% | 0.00% | – |
| Q1 2023 | $526,815 | -15.7% | 264,731 | +0.4% | 0.00% | – |
| Q4 2022 | $624,923 | +15.3% | 263,681 | +0.1% | 0.00% | – |
| Q3 2022 | $542,000 | -17.6% | 263,427 | -0.3% | 0.00% | – |
| Q2 2022 | $658,000 | +6.1% | 264,302 | -2.1% | 0.00% | – |
| Q1 2022 | $620,000 | +6.0% | 269,877 | -0.7% | 0.00% | – |
| Q4 2021 | $585,000 | -26.4% | 271,722 | +1.2% | 0.00% | – |
| Q3 2021 | $795,000 | -16.7% | 268,394 | -1.8% | 0.00% | – |
| Q2 2021 | $954,000 | -9.0% | 273,442 | -4.8% | 0.00% | – |
| Q1 2021 | $1,048,000 | -9.0% | 287,263 | 0.0% | 0.00% | – |
| Q4 2020 | $1,152,000 | -9.2% | 287,263 | 0.0% | 0.00% | – |
| Q3 2020 | $1,269,000 | – | 287,263 | +598364.6% | 0.00% | – |
| Q2 2020 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 48 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 706,930 | $1,406,791 | 1.22% |
| Newtyn Management, LLC | 519,765 | $1,034,332 | 0.20% |
| Murchinson Ltd. | 52,800 | $100,680 | 0.01% |
| Marquette Asset Management, LLC | 17,318 | $34,463 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 46,948 | $93,427 | 0.00% |
| Tekla Capital Management LLC | 32,461 | $64,597 | 0.00% |
| OSAIC HOLDINGS, INC. | 57 | $113 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 42,502 | $84,579 | 0.00% |
| Parallel Advisors, LLC | 244 | $486 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 31 | $62 | 0.00% |